StockNews.com Upgrades BioMarin Pharmaceutical (NASDAQ:BMRN) to “Strong-Buy”
StockNews.com upgraded shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) from a buy rating to a strong-buy rating in a research note published on Monday morning. Other equities analysts have also recently issued reports about the stock. Oppenheimer upgraded shares of BioMarin Pharmaceutical from a “market perform” rating to an “outperform” rating and set a […]
StockNews.com upgraded shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) from a buy rating to a strong-buy rating in a research note published on Monday morning. Other equities analysts have also recently issued reports about the stock. Oppenheimer upgraded shares of BioMarin Pharmaceutical from a “market perform” rating to an “outperform” rating and set a […]
